Pure follicle-stimulating hormone as an adjuvant therapy for selected cases in male infertility during in-vitro fertilization is beneficial

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 93, Issue 1, 2000, Pages 105-108

  Dirnfeld, Marta ^a   Katz, Gad ^a   Calderon, Ilan ^a   Abramovici, Haim ^a   Bider, David ^b  

^a IVF Unit   (Israel)

^b Department of Obstetrics and Gynecology   (Israel)

Author keywords

Fertilization; ICSI; Pure FSH; Severe OTA

Indexed keywords

UROFOLLITROPIN;

ADJUVANT THERAPY; ARTICLE; ASTHENOSPERMIA; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FERTILIZATION IN VITRO; HORMONAL THERAPY; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; MALE; MALE INFERTILITY; OLIGOSPERMIA; PREGNANCY RATE; PRIORITY JOURNAL; SPERMATOZOON MOTILITY; SYNDROME;

EID: 0033796381     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(00)00252-9     Document Type: Article

References (20)

1. Lanzendorf S.E. Experiences with intracytoplasmic sperm injection. Reprod Med Rev. 82:1997;709-716.
2. Schlegel P.N., Girardi S.K. Clinical review 87: In vitro fertilization for male factor infertility. J Clin Endocrinol Metab. 82:1997;709-716.
3. Granberg M., Wikland M., Hamberger L. Cost-effectiveness of intracytoplasmic sperm injection in comparison with donor insemination. Acta Obstet Gynecol. 75:1996;734-737.
4. Kim E.D., Lamb D.J., Lipshultz L.I. Intracytoplasmic sperm injection for treatment of the infertile male. Tex Med. 93:1997;50-56.
5. Acosta A.A., Khalifa E., Oehlinger S.O. Pure human follicle stimulating hormone has a role in the treatment of severe infertility by assisted reproduction. Norfolk total experience. Hum Reprod. 7:1992;1067-1072.
6. Bartoov B., Eltes F., Lunenfeld E., Har-Even D., Lederman H., Lunenfeld B. Sperm quality of subfertile males before and after treatment with human follicle stimulating hormone. Fertil Steril. 61:1994;727-734.
7. Dirnfeld M., Gonen Y., Lissak A., Goldman S., Koijman M., Sorokin Y., et al. A randomized prospective study on the effect of short and long buserelin treatment in women with repeated unsuccessful in vitro fertilization cycles due to inadequate ovarian response. J In Vitro Fert Embryo Trans. 8:1991;339-343.
8. Roh S.I., Awadalla S.G., Friedman C.I., Park J.M., Chin N.O., Dodds W.G., et al. In vitro fertilization and embryo transfer: treatment-dependent versus independent pregnancies. Fertil Steril. 48:1987;982-986.
9. Ben-Rafael Z., Mashiach S., Dor J., Rudak E., Goldman B. Treatment-independent pregnancy after in vitro fertilization and embryo transfer trial. Fertil Steril. 45:1986;564-567.
10. Quinton R., Matfin G., Bouloux P., Loumaye E. Successful induction of fertility in a hypogonadotropic male. (Letter). Lancet. 733:1994;343.
11. Stanton P.G., Robertson D.M., Burgon P.G., Schmauk-White B., Hearn M.T. Isolation and physicochemical characterization with human follicle stimulating hormone isoforms. Endocrinology. 130:1992;2820-2832.
12. Ulloa-Aguirre A., Damian-Matsumara P., Jimenez M., Zambrano E., Diaz-Sanchez V. Biological characterization of the isoforms of urinary human follicle-stimulating hormone contained in a purified commercial preparation. Hum Reprod. 7:1992;1371-1378.
13. Guderman T., Brockman H., Simoni M., Gromoll J., Nieschlag E. In vitro bioassay for human serum follicle stimulating hormone (FSH) based on L cells transfected with recombinant rat FSH receptor: validation of a model system. Endocrinology. 135:1994;2204-2213.
14. Simoni M., Jockenhovel F., Nieschlag E. Polymorphism of human pituitary FSH: analysis of immunoreactivity and in vitro bioactivity of different molecular species. J Endocrinol. 141:1994;359-367.
15. Burgon P.G., Robertson D.M., Stanton P.G., Hearn M.T. Immunological activities of highly purified isoforms of human FSH correlate with in vitro bioactivities. J Endocrinol. 139:1993;511-518.
16. Crottaz B., Senn A., Reymond M.J., Rey F., Germond M., Gomez F. FSH bioactivity in idiopathic normogonadotropic oligoasthenozoospermia: double blind trial with gonadotropin releasing hormone. Fertil Steril. 57:1992;1034-1043.
17. Yong E.L., Lee K.O., Ng S.C., Ratnam S.S. Induction of spermatogenesis in isolated hypogonadotrophic hypogonadism with gonadotrophins and early intervention with intracytoplasmic sperm injection. Hum Reprod. 12:1997;1230-1232.
18. Martin du Pan R.C., Campane A. Physiotherapy of spermatogenic arrest. Fertil Steril. 60:1995;937-946.
19. Mannaerts, B., Fauser, B., Lahlou, N., Harlon, J., Shoham, Z., Coelingh Bennink, H.J.T., Bouchard, P. Serum hormone concentrations during treatment with multiple rising doses of recombinant follicle-stimulating hormone (Puregon*) in men with hypogonadotropic hypogonadism. Fertil Steril 1998;69 (Suppl. 1);24S.
20. Balaban B., Urman B., Sertac A., Alatas C., Aksoy S., Mercan R., Nuhoglu A. In vitro culture of spermatozoa induces motility and increases implantation and pregnancy rates after testicular sperm extraction and intracytoplasmic sperm injection. Hum Reprod. 14:1999;2808-2811.